Toll-like receptor 4 expression during cerebral aneurysm formation: Laboratory investigation

Journal of Neurosurgery

Volumn 113, Issue 4, 2010, Pages 851-858

  Aoki, Tomohiro ^a   Nishimura, Masaki ^a   Ishibashi, Ryota ^a   Kataoka, Hiroharu ^a   Takagi, Yasushi ^a   Hashimoto, Nobuo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cerebral aneurysm; Inflammation; Nuclear factor kappa B; Rat; Toll like receptor

Indexed keywords

ALPHA TUBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; MESSENGER RNA; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERY ANEURYSM; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; GENETICS; HUMAN; INTRACRANIAL ANEURYSM; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL ANEURYSM; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 77957831033     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.9.JNS09329     Document Type: Article

References (57)

1. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 4:499-511, 2004
2. Alnaes MS, Isaksen J, Mardal KA, Romner B, Morgan MK, Ingebrigtsen T: Computation of hemodynamics in the circle of Willis. Stroke 38:2500-2505, 2007
3. Anderson KV, Jurgens G, Nusslein-Volhard C: Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42:779-789, 1985 (Pubitemid 16083719)
4. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Nifedipine inhibits the progression of an experimentally induced cerebral aneurysm in rats with associated down-regulation of NF-kappa B transcriptional activity. Curr Neurovasc Res 5:37-45, 2008 (Pubitemid 351302653)
5. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 39:1276-1285, 2008 (Pubitemid 351440702)
6. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N: Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 38:162-169, 2007
7. Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T, et al: NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation 116:2830-2840, 2007
8. Barton GM, Medzhitov R: Toll-like receptor signaling pathways. Science 300:1524-1525, 2003
9. Bell MP, Svingen PA, Rahman MK, Xiong Y, Faubion WA Jr: FOXP3 regulates TLR10 expression in human T regulatory cells. J Immunol 179:1893-1900, 2007
10. Bjorkbacka H: Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr Opin Lipidol 17:527-533, 2006
11. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A: The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102:956-963, 2003
12. Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S, Petrof BJ: Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin. Infect Immun 74:6829-6838, 2006
13. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR: Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res 72:384-393, 2006
14. Cairns BA, Barnes CM, Mlot S, Meyer AA, Maile R: Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury. J Trauma 64:1069-1077, 2008
15. Carmody RJ, Chen YH: Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4:31-41, 2007
16. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I: Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115:1599-1608, 2007
17. Castro MA, Putman CM, Sheridan MJ, Cebral JR: Hemodynamic patterns of anterior communicating artery aneurysms: a possible association with rupture. AJNR Am J Neuroradiol 30:297-302, 2009
18. Chen LY, Zuraw BL, Zhao M, Liu FT, Huang S, Pan ZK: Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes. Am J Physiol Lung Cell Mol Physiol 284:L607-L613, 2003
19. Curtiss LK, Tobias PS: The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis. Curr Drug Targets 8:1230-1238, 2007
20. Doyle SL, O'Neill LA: Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72:1102-1113, 2006
21. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275:11058-11063, 2000
22. Feigin VL, Findlay M: Advances in subarachnoid hemorrhage. Stroke 37:305-308, 2006
23. Gao L, Hoi Y, Swartz DD, Kolega J, Siddiqui A, Meng H: Nascent aneurysm formation at the basilar terminus induced by hemodynamics. Stroke 39:2085-2090, 2008
24. Gay NJ, Gangloff M: Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76:141-165, 2007
25. Gay NJ, Keith FJ: Drosophila Toll and IL-1 receptor. Nature 351:355-356, 1991
26. Gribar SC, Anand RJ, Sodhi CP, Hackam DJ: The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 83:493-498, 2008.
27. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, et al: Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174:2942-2950, 2005
28. Hashimoto N: Experimental model for producing cerebral aneurysms. J Neurosurg 66:634-635, 1987
29. Hashimoto N, Handa H, Hazama F: Experimentally induced cerebral aneurysms in rats. Surg Neurol 10:3-8, 1978
30. Hashimoto N, Handa H, Hazama F: Experimentally induced cerebral aneurysms in rats: Part III. Pathology. Surg Neurol 11:299-304, 1979 (Pubitemid 9155969)
31. Hashimoto N, Handa H, Nagata I, Hazama F: Experimentally induced cerebral aneurysms in rats: Part V. Relation of hemodynamics in the circle of Willis to formation of aneurysms. Surg Neurol 13:41-45, 1980
32. Hollestelle SC, De Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF, et al: Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109:393-398, 2004
33. Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL, et al: Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol 190:101-111, 2007
34. Hughes AL, Piontkivska H: Functional diversification of the toll-like receptor gene family. Immunogenetics 60:249-256, 2008
35. Jamous MA, Nagahiro S, Kitazato KT, Satoh K, Satomi J: Vascular corrosion casts mirroring early morphological changes that lead to the formation of saccular cerebral aneurysm: an experimental study in rats. J Neurosurg 102:532-535, 2005
36. Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Aziz HA, Shono M, et al: Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J Neurosurg 107:405-411, 2007
37. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H: Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29:181-188, 1998
38. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, et al: Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 190:28-33, 2007
39. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983, 1996
40. Li H, Sun B: Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 11:88-95, 2007
41. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145, 2001
42. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397, 1997
43. Michelsen KS, Arditi M: Toll-like receptor signaling and atherosclerosis. Curr Opin Hematol 13:163-168, 2006
44. Michelsen KS, Doherty TM, Shah PK, Arditi M: Role of Toll-like receptors in atherosclerosis. Circ Res 95:e96-e97, 2004
45. Morimoto M, Miyamoto S, Mizoguchi A, Kume N, Kita T, Hashimoto N: Mouse model of cerebral aneurysm: experimental induction by renal hypertension and local hemodynamic changes. Stroke 33:1911-1915, 2002
46. Nagata I, Handa H, Hashimoto N: Experimentally induced cerebral aneurysms in rats: part IV-cerebral angiography. Surg Neurol 12:419-424, 1979 (Pubitemid 10205102)
47. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, et al: Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109:784-789, 2004
48. Pasterkamp G, Van Keulen JK, De Kleijn DP: Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34:328-334, 2004
49. Riad A, Jager S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D, et al: Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 180:6954-6961, 2008
50. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 95:588-593, 1998
51. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G: Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197:95-104, 2008
52. Shinohara M, Hirata K, Yamashita T, Takaya T, Sasaki N, Shiraki R, et al: Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4. Arterioscler Thromb Vasc Biol 27:2384-2391, 2007
53. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, et al: In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106:1985-1990, 2002
54. Wermer MJ, Kool H, Albrecht KW, Rinkel GJ: Subarachnoid hemorrhage treated with clipping: long-term effects on employment, relationships, personality, and mood. Neurosurgery 60:91-97, 2007
55. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103-110, 2003
56. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, et al: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103-3108, 2001
57. Yang QW, Mou L, Lv FL, Wang JZ, Wang L, Zhou HJ, et al: Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL. Biorheology 42:225-236, 2005